Belli; Barbara A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Belli; Barbara A..The latest application filed is for "methods of treatment using combination therapy".

Company Profile

1.11.10

Belli; Barbara A. - San Diego CA
Belli; Barbara A - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treatment using combination therapy Grant 8,836,218 - Armstrong , et al. September 16, 2	2014-09-16
Methods Of Treatment Using Combination Therapy App 20130137650 - ARMSTRONG; Robert C. ; et al.	2013-05-30
Methods of treatment using combination therapy Grant 8,357,690 - Armstrong , et al. January 22, 2	2013-01-22
Eukaryotic layered vector initiation systems Grant 7,977,091 - Dubensky, Jr. , et al. July 12, 2	2011-07-12
Recombinant Alphavirus-based Vectors With Reduced Inhibition Of Cellular Macro-molecular Synthesis App 20100330121 - Dubensky, JR.; Thomas W. ; et al.	2010-12-30
Methods of treatment using combination therapy App 20100292177 - Armstrong; Robert C. ; et al.	2010-11-18
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 7,811,812 - Dubensky, Jr. , et al. October 12, 2	2010-10-12
Eukaryotic Layered Vector Initiation Systems App 20100173412 - Dubensky, JR.; Thomas W. ; et al.	2010-07-08
Enhancement of the immune response for vaccine and gene therapy applications Grant 7,744,900 - Dubensky, Jr. , et al. June 29, 2	2010-06-29
Eukaryotic layered vector initiation systems Grant 7,572,628 - Dubensky, Jr. , et al. August 11, 2	2009-08-11
Enhancement Of The Immune Response For Vaccine And Gene Therapy Applications App 20080292655 - Dubensky, JR.; Thomas W. ; et al.	2008-11-27
Eukaryotic layered vector initiation systems App 20040029278 - Dubensky, Thomas W. JR. ; et al.	2004-02-12
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis App 20030232058 - Dubensky, Thomas W. JR. ; et al.	2003-12-18
Eukaryotic layered vector initiation systems App 20030232035 - Dubensky, Thomas W. JR. ; et al.	2003-12-18
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis App 20030096397 - Schlesinger, Sondra ; et al.	2003-05-22
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,465,634 - Dubensky, Jr. , et al. October 15, 2	2002-10-15
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,458,560 - Dubensky, Jr. , et al. October 1, 2	2002-10-01
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Grant 6,451,592 - Dubensky, Jr. , et al. September 17, 2	2002-09-17
Alphavirus vector constructs Grant 5,843,723 - Dubensky, Jr. , et al. December 1, 1	1998-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.